Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF – Get Free Report) shares crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $11.29 and traded as low as $10.73. Ono Pharmaceutical shares last traded at $10.73, with a volume of 5,566 shares traded.
Ono Pharmaceutical Price Performance
The business’s 50-day moving average price is $11.29 and its 200 day moving average price is $10.81. The company has a market capitalization of $5.04 billion, a P/E ratio of 10.32 and a beta of 0.57. The company has a quick ratio of 2.80, a current ratio of 3.55 and a debt-to-equity ratio of 0.14.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Recommended Stories
- Five stocks we like better than Ono Pharmaceutical
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Palantir’s Latest Deal Could Put a Freeze on Its Stock Price
- What is a penny stock? A comprehensive guide
- 4 Automaker Stocks React to Tariffs: Winners and Losers
- The How And Why of Investing in Oil Stocks
- Here’s Why Call Option Traders Love Dutch Bros Stock
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
